| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/28/2004 | CN1470236A Multicomponent preparation for treatnig piles and fissure |
| 01/28/2004 | CN1470235A Animal model of schizophrenia and its medicine sorting platform |
| 01/28/2004 | CN1470234A Capsaicin liposome preparation for skin |
| 01/28/2004 | CN1470233A Water-soluble medicine particle-type slow-release composition, preparation and its preparing method |
| 01/28/2004 | CN1136226C Synthesis and anticancer activity of conjugated phospholipid compounds |
| 01/28/2004 | CN1136224C Inositolglycuns having insulin-like action |
| 01/28/2004 | CN1136222C 3-(2-oxo[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems |
| 01/28/2004 | CN1136219C Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 01/28/2004 | CN1136217C 4-aryloxindoles as inhibitor of JNK protein kinases |
| 01/28/2004 | CN1136216C Pyrone carboxy Lic acid derivative or lts salt and antibiotic with the same us effective component |
| 01/28/2004 | CN1136213C New benzothiophene, benzofuran and indole compounds, preparation method there for and medicine composition containing them |
| 01/28/2004 | CN1136212C Thiophene nitrone compounds |
| 01/28/2004 | CN1136208C Intermediate for preparing 2-thiosubstituted carbapenems |
| 01/28/2004 | CN1136203C Benzoxazine and penzothiazine derivatives and their use in pharmaceuticals |
| 01/28/2004 | CN1136201C Pharmacologucally active enantiomers and method for their preparation |
| 01/28/2004 | CN1136200C Pharmacollogically active enantiomers and method for their preparation |
| 01/28/2004 | CN1136199C Process for preparing alpha-adrenergic receptor antagonist |
| 01/28/2004 | CN1136198C Novel benzyl pyrimidines |
| 01/28/2004 | CN1136197C Novel pyridajinone derivatives |
| 01/28/2004 | CN1136196C Crystalline forms of 3-(2,4-dichlorl benzyl)-2-methyl-N-(Pentylsulfonyc)-3H-benzimidzole-5-carboxamide |
| 01/28/2004 | CN1136194C Method for producing particles of hydrory pyrithione salts |
| 01/28/2004 | CN1136193C Imide derivatives ar Salts thereof |
| 01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
| 01/28/2004 | CN1136191C Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/28/2004 | CN1136187C 1-amino-alkylcyclohexane NMDA receptor antagonists |
| 01/28/2004 | CN1136006C Externally applied chinese medicine decoction |
| 01/28/2004 | CN1136003C Exterior-applied ointment for treating dermatitis |
| 01/28/2004 | CN1136002C Chinese-medical buccal lozenge and its preparing process |
| 01/28/2004 | CN1135998C Medicine for curing chicken trachitis |
| 01/28/2004 | CN1135997C Medicine for treating cardiovascular and cerebrovascular diseases |
| 01/28/2004 | CN1135994C Exterior-applied chinese medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
| 01/28/2004 | CN1135989C Maternal immue secretions and their use in treatment and/or prophylaxis of conditions of human body |
| 01/28/2004 | CN1135988C Use of botulinum toxin in preparing pharmaceutical composition for treating prostatic disorders |
| 01/28/2004 | CN1135987C Use of 1-acyl-3,6-hexahydroxy dephenyl-diformacyl glucose compound in preparing medicine for anti-thrombus |
| 01/28/2004 | CN1135986C Vaginal minocycline suppository |
| 01/28/2004 | CN1135985C Minocycline vaginal solution agent |
| 01/28/2004 | CN1135983C Application of diacid (5-androstene-17-one-3 beta-hydroxy) diester in preparing medicine |
| 01/28/2004 | CN1135982C Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine deriratives |
| 01/28/2004 | CN1135981C Morphine sulphate microgranules, and method for making same and pharmaceutical preparations |
| 01/28/2004 | CN1135980C Berberine hydrochloride suppository and its producing method |
| 01/28/2004 | CN1135979C Application of sophocarpine in preparation of medicine for curing coxsackieverus B myocardits and its preparation method |
| 01/28/2004 | CN1135978C Lubricating cream for copulation |
| 01/28/2004 | CN1135977C Application of malaridine in preparing antitumor medicine and tumor tolerance-reversing medicine |
| 01/28/2004 | CN1135976C Application of cotucine in pharmacy |
| 01/28/2004 | CN1135975C Vitamin E and esters therof for use in the topical treatment of mucosal pathologies |
| 01/28/2004 | CN1135974C Antimalarical compound dihydroatremisinin |
| 01/28/2004 | CN1135973C Use of methionine composition in preparation of medicine for curing cardio-cerebral vascular diseases |
| 01/28/2004 | CN1135972C Mixed antigen medicine for treating benign and malignant skin lesion |
| 01/28/2004 | CN1135971C Transdermal preparation containing serotonin receptor antagonist |
| 01/28/2004 | CN1135969C Aqueous pharmaceutical composition comprising active ingredient which is highly insoluble in water |
| 01/27/2004 | USRE38407 Administering composition containing liposome-encapsulated opioid analgesic agent through patient's pulmonary system |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683200 N-substituted-n'-substituted urea derivative is used as a tumor necrosis factor-alpha production inhibitory agent and a therapeutical agent for autoimmune diseases |
| 01/27/2004 | US6683192 Substituted benzo(b)thien compounds useful for modulating proliferation or differentiation of a cell, agonizes hedgehog mediated signal trasnduction with an ed50 of 1mm or less |
| 01/27/2004 | US6683186 2,3-Disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| 01/27/2004 | US6683183 Bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, for treatment of proliferative disorders |
| 01/27/2004 | US6683181 Mixing polystyrene-tosyl chloride resin with c2-12alkynol; reacting with amine to make chemical intermediate; herpes virus treatment |
| 01/27/2004 | US6683172 Composition for inhibiting inflammatory response comprising at least one nucleic acid molecule selected from specified sequences |
| 01/27/2004 | US6683163 Monitoring angiogenesis factor |
| 01/27/2004 | US6683116 Primarily comprised of tetracosanol, hexacosanol, octacosanol and triacontanol; hydrolysis and neutralization; obesity, syndrome x, diabetes, hypercholesterolemia, atherosclerotic complications, ischemia, thrombosis |
| 01/27/2004 | US6683114 Using norepinephrine reuptake inhibitors such as tomoxetine hydrochloride |
| 01/27/2004 | US6683112 Gabapentin prodrugs and formulations |
| 01/27/2004 | US6683111 Such as 2-ethoxy-3-(4-(2-xanthen-9-ylidene-ethoxy)-phenyl)-propionic acid; for treating conditions associated with peroxisome proliferator-activated receptors; treatment of diabetes/obesity |
| 01/27/2004 | US6683110 4-(4-ethoxyphenyl)-2-(n'-fluoren-9-ylidenehydrazino)-2-hydroxy -4-oxobutyric acid methyl ester; 2-(4-bromophenyl-amino)-5,5-dimethyl-4-oxohex-2-enoic acid methyl ester |
| 01/27/2004 | US6683109 Condensation derivatives of thiocolchicine and baccatin as antitumor agents |
| 01/27/2004 | US6683108 Agonists of hedgehog signaling pathways and uses related thereto |
| 01/27/2004 | US6683105 Highly selective butyrylcholinesterase inhibitors such as cymserine or others can prevent or treat cognitive impairments associated with aging or alzheimer's disease |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/27/2004 | US6683102 Methods of using metaxalone in the treatment of musculoskeletal conditions |
| 01/27/2004 | US6683101 Such as 6-(3-(trans-4-phenylcyclohexylamino)propyl)-3h-benzoxazol-2-one; cerebral vascular disorders |
| 01/27/2004 | US6683098 Use of drug miglitol (Glyset) for treatment of obesity to prevent weight gain for losing weight and for weight control |
| 01/27/2004 | US6683097 Imidazole derivatives |
| 01/27/2004 | US6683096 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 01/27/2004 | US6683095 CDK inhibitors having 3-hydroxychromen-4-one structure |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683091 Heterocyclic sulfanamides; alzheimer's disease; preventing deposition of amyloid protein |
| 01/27/2004 | US6683090 N-(1-azabicyclo(2.2.2)oct-3-yl)propenamide derivatives; psychotic and intellectual impairment disorders |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683087 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 01/27/2004 | US6683086 Ultrashort acting hypnotic barbiturates |
| 01/27/2004 | US6683084 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections |
| 01/27/2004 | US6683083 Using less toxic agents such as 1-(1-4-(diphenylmethyl)-piperazinyl)-3-(1-(4-(4-chlorophenyl)-4 -hydroxy)piperidinyl)-2-propanol; inhibiting fibroblast proliferation |
| 01/27/2004 | US6683081 Triazolotriazinones and the use thereof |
| 01/27/2004 | US6683080 Treatment of diabetes mellitus |
| 01/27/2004 | US6683079 Reverse transcriptase inhibitors |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683077 2-Amino-benzoxazinones for the treatment of viral infections |
| 01/27/2004 | US6683076 Methods for therapeutic use of glucosylceramide synthesis inhibitors and composition thereof |
| 01/27/2004 | US6683075 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
| 01/27/2004 | US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/27/2004 | US6683072 Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia |
| 01/27/2004 | US6683071 Initiation of oestrus |
| 01/27/2004 | US6683069 Applying retinoid or c-jun inhibitor several hours before exposure |
| 01/27/2004 | US6683068 For therapy of tetracycline compound-responsive states, such as bacterial infections and neoplasms |
| 01/27/2004 | US6683067 Formulations for treating or preventing mucositis |
| 01/27/2004 | US6683066 Composition and treatment method for brain and spinal cord injuries |
| 01/27/2004 | US6683065 Method of treating body insect infestation |
| 01/27/2004 | US6683063 Lipopolysaccharide disorders |